======= ZRANB2 ======= == Gene Information == * **Official Symbol**: ZRANB2 * **Official Name**: zinc finger RANBP2-type containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9406|9406]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95218|O95218]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZRANB2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZRANB2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604347|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Splice factor required for alternative splicing of TRA2B/SFRS10 transcripts. May interfere with constitutive 5'- splice site selection. {ECO:0000269|PubMed:11448987}. |zf-RanBP| |lipopolysaccharide binding| |RNA splicing| |mRNA processing| |DNA-binding transcription factor activity| |mRNA metabolic process| |RNA processing| |RNA binding| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-2.98| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|-2.54| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|-2.44| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|-2.28| |[[:results:exp340|BN82002 4μM R07 exp340]]|-1.95| |[[:results:exp348|Cyclosporin-A 3μM R07 exp348]]|-1.94| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|-1.93| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-1.88| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.85| |[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|-1.84| |[[:results:exp239|PFI-2 4μM R05 exp239]]|-1.84| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|-1.83| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|-1.79| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|-1.74| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-1.73| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|-1.72| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.78| |[[:results:exp85|UM0129480 7μM R02 exp85]]|1.85| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|1.89| |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|1.9| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.97| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.15| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|3.28| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 13/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|2/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|1/20| |lung|1/75| |lymphocyte|2/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14660 * **Expression level (log2 read counts)**: 7.89 {{:chemogenomics:nalm6 dist.png?nolink |}}